Search Results
PHA-665752 10mg 10mg | Purity Not Available
Adooq Bioscience
PF-2341066 50mg 50mg | Purity Not Available
Adooq Bioscience
PF-2341066 (Crizotinib) is an inhibitor of the c-Met kinase and the NPM-ALK. PF-2341066 inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM).
More Information Supplier PagePF-2341066 5mg 5mg | Purity Not Available
Adooq Bioscience
PF-2341066 (Crizotinib) is an inhibitor of the c-Met kinase and the NPM-ALK. PF-2341066 inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM).
More Information Supplier PagePF-2341066 100mg 100mg | Purity Not Available
Adooq Bioscience
PF-2341066 (Crizotinib) is an inhibitor of the c-Met kinase and the NPM-ALK. PF-2341066 inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM).
More Information Supplier PagePF-2341066 10mg 10mg | Purity Not Available
Adooq Bioscience
PF-2341066 (Crizotinib) is an inhibitor of the c-Met kinase and the NPM-ALK. PF-2341066 inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM).
More Information Supplier PagePF-04217903 50mg 50mg | Purity Not Available
Adooq Bioscience
PF-04217903 is a novel c-Met/hepatocyte growth factor receptor tyrosine kinase inhibitors.
More Information Supplier PagePelitinib 100mg 100mg | Purity Not Available
Adooq Bioscience
Pelitinib (EKB-569) is a 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity.
More Information Supplier PagePelitinib 10mg 10mg | Purity Not Available
Adooq Bioscience
Pelitinib (EKB-569) is a 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity.
More Information Supplier PagePD98059 50mg 50mg | Purity Not Available
Adooq Bioscience
PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase.
More Information Supplier Page